2026 Mission: 10,000 People into Treatment Join Our Mission
Home › Resources › Blog › Drug Abuse Statistics: U.S. Prevalence, Overdose Deaths, Treatment & Trends [Latest Data]

Drug Abuse Statistics: U.S. Prevalence, Overdose Deaths, Treatment & Trends [Latest Data]

Uncategorized
· 8 min read · Updated January 28, 2026

Understanding the scope of substance use in America requires looking at multiple data sources. Here’s what the latest national surveys and drug abuse statistics reveal about who’s using substances, who’s dying from overdoses, and where the treatment gaps exist.

Webserv helps you reach the people who need it most. Learn about our messaging strategy for SUD treatment centers. Every treatment center has a story, but not every story connects. We help you uncover what truly sets your program apart and craft messaging that resonates with the people who matter most: patients and families.

How Drug Use Data is Tracked

Different surveys measure substance use in different ways:

  • NSDUH (National Survey on Drug Use and Health) uses household interviews to estimate past-month and past-year use, plus substance use disorder prevalence
  • Monitoring the Future surveys students in grades 8, 10, and 12 to track adolescent trends
  • N-SSATS (National Survey of Substance Abuse Treatment Services) monitors treatment capacity nationwide
  • Various peer-reviewed scientific publications monitor drug use with sample populations and voluntary participation
  • Government-tracked population health data from various initiatives

Drug Use Prevalence Statistics

What does drug use look like in America today? Here is what we know about the prevalence of drug use, what substances are being used, and the health implications for the American population.

  1. 73.6 million people aged 12 or older (25.5%) used illicit drugs in the past year in 2024.
  1. 64.2 million people used marijuana in the past year in 2024, making it the most commonly used illicit drug.
  1. 48.4 million people aged 12 or older (16.8%) had a substance use disorder in 2024.
  1. 27.9 million people aged 12 or older (9.7%) had alcohol use disorder in 2024.
  1. 7.6 million people misused prescription opioids in the past year in 2024.
  1. 4.8 million people aged 12 or older (1.7%) had an opioid use disorder in 2024.
  1. 10.4 million people used hallucinogens in the past year in 2024.
  1. Drug overdose deaths decreased to approximately 80,391 in 2024, representing a 26.9% decline from 2023.
  1. 57.9 million people aged 12 or older (20.1%) reported binge drinking in the past month in 2024.
  1. 134.3 million people aged 12 or older used alcohol in the past month in 2024.
  1. Only 19.3% (10.2 million people) of those who needed substance use treatment received it in 2024.
  1. 61.5 million adults (23.4%) had any mental illness in 2024, with 34.5% also having a co-occurring substance use disorder.
  1. 74.3% of adults who perceived they ever had a problem with drug or alcohol use considered themselves to be in recovery or recovered.
  1. Opioid overdose deaths decreased to 54,743 in 2024, down from 83,140 in 2023.
  1. 69% of all overdose deaths in 2023 involved synthetic opioids, primarily illegally manufactured fentanyl.
  1. 72,776 deaths involved synthetic opioids other than methadone (primarily fentanyl) in 2023.
  1. 15.4% of adolescents aged 12 to 17 (3.8 million) experienced a major depressive episode in 2024.
  1. Only 17.0% (818,000) of people with opioid use disorder received medications for opioid use disorder (MOUD) in 2024.
  1. Past-year marijuana use disorder increased from 5.1% in 2021 to 6.1% in 2024 among people aged 12 or older.
  1. 47% of drug overdose deaths in 2023 involved both opioids and stimulants (polysubstance use).

Overdose Death Statistics

An overdose death is the ultimate signal that community services and healthcare have failed people when they are at their most vulnerable. Let’s take a look at the overdose death statistics in America right now:

  1. Approximately 80,391 drug overdose deaths occurred in the United States during 2024, representing a 26.9% decrease from 2023.
  1. Drug overdose deaths in 2024 reached their lowest level since 2019.
  1. 105,007 people died from drug overdoses in 2023, down from 107,941 in 2022.
  1. 806,000 people died from opioid overdoses between 1999 and 2023.
  1. Synthetic opioid overdose deaths (primarily fentanyl) decreased to 54,743 in 2024, down from 83,140 in 2023.
  1. 72,776 deaths involved synthetic opioids other than methadone (primarily fentanyl) in 2023.
  1. 69% of all overdose deaths in 2023 involved synthetic opioids, primarily illegally manufactured fentanyl.
  1. Fentanyl was responsible for approximately 199 deaths per day in 2023.
  1. Over 250,000 Americans have died from fentanyl overdoses since 2021.
  1. 76% of drug overdose deaths in 2023 involved an opioid (prescription or illegal).
  1. Heroin-involved overdose deaths decreased approximately 33% from 2022 to 2023, with 3,984 deaths in 2023.
  1. Prescription opioid overdose deaths decreased to 13,026 in 2023, down from 17,029 in 2017.
  1. 29,449 overdose deaths involved cocaine in 2023, representing an 85% increase from 2019.
  1. 34,855 overdose deaths involved psychostimulants with abuse potential (primarily methamphetamine) in 2023.
  1. 47% of drug overdose deaths in 2023 involved both opioids and stimulants (polysubstance overdoses).
  1. 10,870 drug overdose deaths involved benzodiazepines in 2023, with nearly 70% also involving fentanyl.
  1. West Virginia had the highest fentanyl overdose death rate at 69.2 deaths per 100,000 people in 2023.
  1. 45 states showed declines in overdose deaths in the most recent 12-month period ending September 2024, while five states (Alaska, Montana, Nevada, South Dakota, and Utah) saw increases.
  1. Young adults aged 25-34 and adults aged 35-44 accounted for over half of all fentanyl deaths in recent data.
  1. Overdose remains the leading cause of death for Americans aged 18-44.

Drug Treatment Statistics

Substance abuse disorder can be treated, but are people able to access help when they needed? Let’s take a look at what the data shows us.

  1. Only 19.3% (10.2 million people) of those aged 12 or older who needed substance use treatment in 2024 actually received it, meaning 80% who needed treatment did not receive it.
  1. 48.4 million people aged 12 or older (16.8%) had a substance use disorder in 2024.
  1. Only 17.0% (818,000 people) of the 4.8 million people with opioid use disorder received medications for opioid use disorder (MOUD) in 2024.
  1. Only 2.5% (697,000 people) of the 27.9 million people with alcohol use disorder received medications for alcohol use disorder (MAUD) in 2024.
  1. In 2022, only 25.1% of U.S. adults who needed opioid use disorder treatment received medications for OUD.
  1. 42.7% of adults who needed OUD treatment in 2022 did not perceive that they needed treatment.
  1. 30.0% of adults who needed OUD treatment in 2022 received treatment without medications for OUD.
  1. 72.1% of adolescents aged 12 to 17 with co-occurring major depressive episode and substance use disorder received either substance use treatment or mental health treatment in 2024.
  1. 74.3% of adults who perceived they ever had a problem with alcohol or drug use considered themselves to be in recovery or recovered in 2024.
  1. 66.9% of adults who perceived they ever had a mental health issue considered themselves to be in recovery or recovered in 2024.
  1. Only 33% of opioid treatment programs (OTPs) offered all three FDA-approved medications for opioid use disorder (methadone, buprenorphine, and naltrexone) in 2017, increasing to 45% by 2023.
  1. More than 70% of residential treatment programs across the United States do not offer medications for opioid use disorder.
  1. 86.6% of people with opioid use disorder are not receiving medications for OUD, according to data from 2010-2019.
  1. Medications for opioid use disorder reduce the risk of overdose death by approximately 50% or more.
  1. MOUD reduces illicit opioid use by up to 90% among those receiving treatment.
  1. 52.1% (32.0 million) of the 61.5 million adults with any mental illness in 2024 received mental health treatment in the past year.
  1. 70.8% (10.3 million) of the 14.6 million adults with serious mental illness in 2024 received mental health treatment in the past year.
  1. 4.4% of adults and 6.7% of adolescents with substance use disorder who did not receive treatment in 2024 thought they should have been able to access it.
  1. Among adults aged 18 or older in 2024, 33.0% (86.6 million people) had either any mental illness or a substance use disorder in the past year.
  1. Among the 61.5 million adults with any mental illness in 2024, 34.5% (21.2 million) also had a co-occurring substance use disorder.

Drug & Substance Abuse Trends (2020-2026)

Drug and substance use trends are always changing, from the emergence of social media dealers to the burgeoning population of kratom addictions. Here are some of the latest SUD trends to keep an eye on.

Emerging Synthetic Drugs & Adulterants

  1. Xylazine (“Tranq” or “Zombie Drug”) emergence – This veterinary sedative mixed with fentanyl creates prolonged sedation that naloxone cannot reverse, causes severe skin ulcers and necrosis, and was involved in 11% of all U.S. overdose deaths in 2022, up from virtually zero in 2015.
  1. Medetomidine detection surge – A veterinary anesthetic even more powerful than xylazine emerged in the drug supply in 2024-2025, detected in 37% of opioid samples by October 2025 (compared to 4% in May 2024), causing severe withdrawal symptoms requiring ICU care.
  1. Nitazenes arrival – Synthetic opioids up to 100 times stronger than fentanyl emerged in the U.S. market, with some variants being 500 times more potent than morphine and resistant to standard naloxone dosing.
  1. Declining fentanyl purity – DEA laboratories reported a downward trend in the purity of fentanyl powder on the streets, yet overdose rates remained high due to increasing potency of adulterants.
  1. Fentanyl pill seizures skyrocketed – Law enforcement seized 2,300 times more fentanyl pills in 2023 (115.5 million) compared to 2017 (49,657), with pills now representing 49% of all fentanyl seizures versus 10% in 2017.

Counterfeit Pills & Youth Impact

  1. Lethality of counterfeit pills increased dramatically – The percentage of fake pills containing lethal fentanyl doses rose from 40% (2020-2021) to 60% (2022) to 70% (2023-2024).
  1. Fentanyl became the leading cause of death in youth aged 15-24 – Fentanyl-only deaths now account for the majority of fatal overdoses in this age group, despite overall teen drug use declining.
  1. Social media drug marketplaces exploded – 80% of teen and young adult fentanyl poisoning deaths can be traced to some social media contact, with platforms like Snapchat, Instagram, TikTok, and Telegram becoming “open-air drug markets.”
  1. “One Pill Can Kill” became reality – Just 2 milligrams of fentanyl (the amount on the tip of a pencil) can be lethal, and counterfeit pills are virtually indistinguishable from legitimate prescriptions.
  1. Snapchat became a primary drug distribution platform – Over 1,100 cases in DEA’s “Operation Last Mile” involved social media apps, with disappearing messages feature facilitating untraceable drug transactions.

Regional & Geographic Patterns

  1. Western U.S. fentanyl contamination crisis – By 2025, one in two drug deaths in the Western region were linked to fentanyl contamination of cocaine or methamphetamine, compared to one in three in the Eastern U.S.
  1. Nevada’s methamphetamine predominance – Nevada became an outlier where methamphetamine caused more deaths than fentanyl by 2024-2025.
  1. Regional shifts in fentanyl supply – The Western U.S., which historically had fewer fentanyl seizures, now accounts for the most law enforcement seizures of fentanyl, with 77.8% of Western fentanyl seizures being pills in 2023.

Polysubstance Use Trends

  1. Polysubstance overdose deaths surged – 47% of drug overdose deaths in 2023 involved both opioids and stimulants, marking a “fourth wave” of the opioid epidemic.
  1. Cocaine-fentanyl combinations increased 85% – Cocaine-involved deaths rose 85% from 2019 to 2023, driven primarily by fentanyl contamination.
  1. Stimulant contamination with fentanyl – Users of stimulants like cocaine and methamphetamine increasingly died from accidental fentanyl exposure, with many victims having no opioid tolerance.
  1. Methamphetamine production at record levels – Southeast Asia saw record levels of methamphetamine production, particularly in Myanmar’s Shan State.

COVID-19 Pandemic Impact (2020-2022)

  1. 93,000 overdose deaths in 2020 – Drug overdose deaths spiked to an estimated 93,000 in the first year of the pandemic, marking an unprecedented increase.
  1. Social isolation increased solitary drug use – People using drugs alone became more common during lockdowns, dramatically increasing overdose death risk due to lack of immediate help.
  1. 13% of Americans increased substance use during COVID-19 – By June 2020, 13% of Americans reported starting or increasing substance use to cope with pandemic-related stress.
  1. 18% immediate increase in overdoses – The early months of the pandemic brought an 18% increase nationwide in overdoses compared to 2019 levels.
  1. Treatment disruptions worsened outcomes – Closures and disruptions to in-person treatment, methadone clinics, harm reduction services, and support groups contributed to rising deaths.
  1. Mental health crisis accelerated substance use – Reports of anxiety or depression jumped from 1 in 10 adults pre-pandemic to 4 in 10 during the pandemic, correlating with increased substance use.

Dramatic Decline Period (2023-2025)

  1. Historic overdose death decline in 2024 – Drug overdose deaths decreased 26.9% from 2023 to 2024, reaching approximately 80,391 deaths—the lowest level since 2019 and the largest single-year reduction ever recorded.
  1. 11 consecutive months of decline – From October 2023 through October 2024, the U.S. saw 11 consecutive months of declining overdose deaths.
  1. State-level improvements – Michigan, West Virginia, Louisiana, Ohio, Virginia, Wisconsin, and Washington D.C. experienced overdose death reductions exceeding 35% between 2023 and 2024.

Treatment & Response Trends

  1. Naloxone accessibility expanded – Over-the-counter naloxone availability and community distribution programs significantly increased, contributing to declining death rates.
  1. Buprenorphine prescribing barriers removed – The elimination of the X-Waiver requirement in the MAT Act allowed all healthcare providers with DEA licenses to prescribe buprenorphine, dramatically expanding access.
  1. Treatment gap remained massive – Despite progress, 80% of people who needed substance use treatment in 2024 did not receive it, and only 17% of those with opioid use disorder received MOUD.
  1. Gas station drugs proliferated – Substances like tianeptine (“gas station heroin”), Delta-8 THC, kratom, and synthetic cannabinoids became widely available at convenience stores, creating new addiction pathways particularly dangerous for youth.

What Drug Abuse Statistics Tell Us & What to Do Next

These statistics paint a portrait of both peril and promise in America’s ongoing struggle with substance use. While 2024’s historic 27% decline in overdose deaths proves that progress is possible, a devastating paradox remains: medications for opioid use disorder reduce overdose deaths by 50% and cut illicit opioid use by 90%, yet 80% of people who need treatment never receive it

Most heartbreaking is that fentanyl has become the leading cause of death for Americans aged 15-44, with social media platforms transformed into “open-air drug markets” where teenagers can order lethal pills with a few taps.

The path forward requires coordinated action at every level of society. At the governmental level, we must dismantle the regulatory and financial barriers that keep evidence-based treatment out of reach—expanding

Medicaid coverage for MOUD, requiring all residential treatment programs to offer medications, and holding social media companies legally accountable for facilitating drug sales that kill children. Healthcare systems must integrate substance use disorder treatment into primary care, train every provider to prescribe buprenorphine, and eliminate the stigma that keeps treatment siloed from mainstream medicine.

These statistics represent individual human beings—someone’s child, parent, sibling, or friend. If you or someone you love is struggling, recovery is possible. Call SAMHSA’s National Helpline at 1-800-662-HELP (4357) for free, confidential treatment referrals 24/7, or text 988 for crisis support.

What Treatment Centers Need to Know

Treatment centers know all of this better than most. But what can they do with this information?

1. Meet People Where They Are Seeking Help—Online

When someone is ready to seek help for substance use, they’re Googling “rehab near me” at 2 AM, searching “fentanyl withdrawal symptoms” in desperation, or typing “opioid treatment that takes Medicaid” after insurance denial. These searchers represent the 80% who need treatment but aren’t receiving it.

If your center doesn’t appear in those critical moments, you’ve lost the opportunity to save a life. Yet many treatment centers have outdated websites, incorrect Google profiles, and search visibility so poor that families find predatory patient brokers before legitimate care.

Digital visibility isn’t vanity—it’s a public health imperative.

Strategic treatment center SEO means appearing when someone searches for specific help they need. Educational content about today’s drug supply builds trust before crisis hits. Clear, compassionate website information helps people find evidence-based care instead of becoming part of the 220 daily overdose deaths.

At Webserv, we help addiction treatment centers bridge this gap between crisis and care, ensuring that when someone finally reaches for help, they find a lifeline.

2. Prepare for Polysubstance Use and an Unpredictable Drug Supply

Your intake assessments must evolve to match today’s reality: 47% of overdose deaths now involve both opioids and stimulants, fentanyl is contaminating cocaine and methamphetamine, and patients may be unknowingly exposed to xylazine, medetomidine, or nitazenes that require different medical management than traditional opioids.

A patient who thinks they’re using “just cocaine” or “just Xanax” may actually be using fentanyl, and standard naloxone protocols won’t reverse xylazine’s sedative effects. Treatment centers need comprehensive toxicology screening beyond standard drug panels, staff trained to manage complex withdrawal from multiple substances simultaneously, and medical protocols that account for adulterants.

3. Eliminate Barriers and Meet People Where They Are

The fact that 80% of people who need treatment don’t receive it isn’t just a personal failure—it’s a systems failure that treatment centers perpetuate through unnecessary barriers to entry. Waiting lists, insurance complications, requirements for “motivation” or past abstinence, rigid program schedules that don’t accommodate jobs or childcare, and discharge for positive drug tests all keep people from the care that could save their lives.

Same-day access, low-barrier entry, harm reduction philosophies, telehealth options for ongoing care, flexible scheduling, and meeting patients at their current stage of change—not where you wish they were—are no longer progressive ideas but survival necessities. Every day someone spends on a waiting list or turned away for the “wrong” insurance is another day they’re at risk of becoming one of the 220 daily overdose deaths.

4. Your Staff Are Frontline Responders to a Public Health Emergency

The substance use landscape has transformed so rapidly that clinical knowledge from even five years ago is dangerously outdated, yet many treatment centers still operate with staff trained in an era when heroin and prescription pills were the primary threats.

Today’s counselors, intake specialists, and support staff need to understand that xylazine causes skin necrosis that doesn’t respond to typical wound care, that medetomidine can trigger severe withdrawal requiring ICU-level monitoring, that nitazenes resist standard naloxone dosing, and that the 15-24-year-old demographic is dying from fentanyl they ordered on social media believing it was legitimate medication. This isn’t specialty knowledge—it’s baseline competency for 2025.

Every staff member should receive quarterly training on emerging drug trends, be able to identify symptoms of novel adulterants, understand polysubstance withdrawal protocols, and know how to have informed conversations with families about today’s drug supply.

Your intake staff need to ask not just “what drugs do you use?” but “where do you get them?” because understanding social media procurement patterns, counterfeit pill identification, and regional contamination trends directly impacts treatment planning.

Drug Abuse Statistics FAQ

Here are some questions people also ask about drug abuse statistics:

What are the statistics of drug abuse in the US?

Over 48 million Americans aged 12 and older struggled with substance use disorder in recent years, affecting approximately 17% of the population. Drug overdose deaths have exceeded 100,000 annually, with opioids and synthetic substances like fentanyl contributing to the majority of fatalities.

What is the #1 drug of abuse in the United States?

Alcohol remains the most commonly abused substance in America, with over 29 million people meeting criteria for alcohol use disorder. However, marijuana has the highest number of regular users among illicit drugs, followed by prescription opioids and stimulants.

What is the definition of drug abuse?

Drug abuse is the harmful or hazardous use of psychoactive substances in a way that damages physical or mental health, impairs functioning, or leads to dangerous behaviors. It involves using drugs in amounts, frequencies, or circumstances that exceed medical recommendations or social norms.

What are the five causes of drug abuse?

The primary causes include genetic predisposition (family history increases risk by 40-60%), environmental factors like trauma or peer pressure, mental health conditions such as depression or anxiety, early exposure to substances during adolescence, and lack of healthy coping mechanisms for stress. These factors often interact and compound one another, making addiction a complex disease with multiple contributing elements.

What is an example of drug abuse?

Taking prescription painkillers in higher doses or more frequently than prescribed demonstrates drug abuse, especially when done to achieve euphoria rather than pain relief. Another common example is binge drinking alcohol to the point of blackouts or dangerous intoxication despite negative consequences.

What are the five effects of drug abuse on youth?

Youth who abuse drugs experience impaired brain development affecting decision-making and impulse control, declining academic performance and increased school dropout rates, higher risk of mental health disorders including depression and anxiety, damaged relationships with family and peers, and increased likelihood of legal problems or criminal activity. These effects can have lasting impacts well into adulthood, making early intervention critical.

References

Centers for Disease Control and Prevention. (2024). Drug overdose deaths in the United States, 2003–2023 (NCHS Data Brief No. 522). National Center for Health Statistics. https://www.cdc.gov/nchs/products/databriefs/db522.htm

Centers for Disease Control and Prevention. (2025, May 14). U.S. overdose deaths decrease almost 27% in 2024 [Press release]. https://www.cdc.gov/nchs/pressroom/releases/20250514.html

Centers for Disease Control and Prevention. (2025). About overdose prevention. https://www.cdc.gov/overdose-prevention/about/index.html

Garnett, M. F., & Miniño, A. M. (2024). Drug overdose deaths in the United States, 2002–2022 (NCHS Data Brief No. 491). National Center for Health Statistics. https://doi.org/10.15620/cdc/170565

Substance Abuse and Mental Health Services Administration. (2025). Key substance use and mental health indicators in the United States: Results from the 2024 National Survey on Drug Use and Health (HHS Publication No. PEP25-07-007, NSDUH Series H-60). Center for Behavioral Health Statistics and Quality. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health/national-releases

Substance Abuse and Mental Health Services Administration. (2025, July 28). SAMHSA releases annual national survey on drug use and health [Press release]. https://www.samhsa.gov/newsroom/press-announcements/20250728/samhsa-releases-annual-national-survey-on-drug-use-and-health

Centers for Disease Control and Prevention. (2024). Drug overdose deaths in the United States, 2003–2023 (NCHS Data Brief No. 522). National Center for Health Statistics. https://www.cdc.gov/nchs/products/databriefs/db522.htm

Centers for Disease Control and Prevention. (2025, January 16). Data resources. Overdose Prevention. https://www.cdc.gov/overdose-prevention/data-research/facts-stats/index.html

Centers for Disease Control and Prevention. (2025, February 25). CDC reports nearly 24% decline in U.S. drug overdose deaths [Press release]. https://www.cdc.gov/media/releases/2025/2025-cdc-reports-decline-in-us-drug-overdose-deaths.html

Centers for Disease Control and Prevention. (2025, May 14). U.S. overdose deaths decrease almost 27% in 2024 [Press release]. https://www.cdc.gov/nchs/pressroom/releases/20250514.html

Centers for Disease Control and Prevention. (n.d.). About overdose prevention. https://www.cdc.gov/overdose-prevention/about/index.html

Centers for Disease Control and Prevention. (n.d.). Products – Vital statistics rapid release – Provisional drug overdose data. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

Centers for Disease Control and Prevention. (n.d.). Understanding the opioid overdose epidemic. https://www.cdc.gov/overdose-prevention/about/understanding-the-opioid-overdose-epidemic.html

Garnett, M. F., & Miniño, A. M. (2024). Drug overdose deaths in the United States, 2002–2022 (NCHS Data Brief No. 491). National Center for Health Statistics. https://doi.org/10.15620/cdc/170565

National Institute on Drug Abuse. (2024, August 21). Drug overdose deaths: Facts and figures. https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates

Overdose Lifeline. (2025). 2024 opioid overdose data report: Key trends and insights. https://www.overdoselifeline.org/news/2024-opioid-overdose-data-report-key-trends-and-insights/

USAFacts. (2025, October 24). Are fentanyl overdose deaths rising in the US? https://usafacts.org/articles/are-fentanyl-overdose-deaths-rising-in-the-us/

Centers for Disease Control and Prevention. (2024, June 27). Treatment for opioid use disorder: Population estimates—United States, 2022. Morbidity and Mortality Weekly Report, 73(25), 567–574. https://www.cdc.gov/mmwr/volumes/73/wr/mm7325a1.htm

Centers for Disease Control and Prevention. (n.d.). Medications for opioid use disorder (MOUD) study. https://www.cdc.gov/overdose-prevention/data-research/facts-stats/moud-study.html

Centers for Disease Control and Prevention. (n.d.). Treatment of opioid use disorder. https://www.cdc.gov/overdose-prevention/treatment/opioid-use-disorder.html

Dever, J. A., Hertz, M. F., Dunlap, L. J., Richardson, J. S., Wolicki, S. B., Biggers, B. B., Edlund, M. J., Bohm, M. K., Turcios, D., Jiang, X., Zhou, H., Evans, M. E., & Guy, G. P., Jr. (2024). The medications for opioid use disorder study: Methods and initial outcomes from an 18-month study of patients in treatment for opioid use disorder. Public Health Reports, 139(4), 484–493. https://doi.org/10.1177/00333549231222479

Krawczyk, N., Rivera, B. D., Jent, V., Keyes, K. M., Jones, C. M., & Cerdá, M. (2021). Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019. International Journal of Drug Policy, 110, 103786. https://doi.org/10.1016/j.drugpo.2021.103786

National Association of Counties. (2025, August 13). SAMHSA releases new 2024 data on rates of mental illness and substance use disorder in the U.S. https://www.naco.org/news/samhsa-releases-new-2024-data-rates-mental-illness-and-substance-use-disorder-us

NYU Langone Health. (2022, August 4). Almost 90 percent of people with opioid use disorder not receiving lifesaving medication [Press release]. https://nyulangone.org/news/almost-90-percent-people-opioid-use-disorder-not-receiving-lifesaving-medication

Substance Abuse and Mental Health Services Administration. (2025). Key substance use and mental health indicators in the United States: Results from the 2024 National Survey on Drug Use and Health (HHS Publication No. PEP25-07-007, NSDUH Series H-60). Center for Behavioral Health Statistics and Quality. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health/national-releases

Substance Abuse and Mental Health Services Administration. (2025, July 28). SAMHSA releases annual national survey on drug use and health [Press release]. https://www.samhsa.gov/newsroom/press-announcements/20250728/samhsa-releases-annual-national-survey-on-drug-use-and-health

Substance Abuse and Mental Health Services Administration. (n.d.). 2024 National Substance Use and Mental Health Services Survey (N-SUMHSS): Data on substance use and mental health treatment facilities. https://www.samhsa.gov/data/report/2024-n-sumhss-annual-report

Substance Abuse and Mental Health Services Administration. (n.d.). 2026 Substance Use Disorder Treatment Month. https://www.samhsa.gov/about/digital-toolkits/substance-use-disorder-treatment-month

U.S. Food and Drug Administration. (n.d.). Information about medications for opioid use disorder (MOUD). https://www.fda.gov/drugs/information-drug-class/information-about-medications-opioid-use-disorder-moud

Based on recent data from SAMHSA, CDC, DEA, and other authoritative sources, here are 30 interesting or alarming drug and substance abuse trends that have emerged between 2020-2026:

Drug & Substance Abuse Trends (2020-2026)

Emerging Synthetic Drugs & Adulterants

  1. Xylazine (“Tranq” or “Zombie Drug”) emergence: This veterinary sedative mixed with fentanyl creates prolonged sedation that naloxone cannot reverse, causes severe skin ulcers and necrosis, and was involved in 11% of all U.S. overdose deaths in 2022, up from virtually zero in 2015.
  2. Medetomidine detection surge: A veterinary anesthetic even more powerful than xylazine emerged in the drug supply in 2024-2025, detected in 37% of opioid samples by October 2025 (compared to 4% in May 2024), causing severe withdrawal symptoms requiring ICU care.
  3. Nitazenes arrival: Synthetic opioids up to 100 times stronger than fentanyl emerged in the U.S. market, with some variants being 500 times more potent than morphine and resistant to standard naloxone dosing.
  4. Declining fentanyl purity: DEA laboratories reported a downward trend in the purity of fentanyl powder on the streets, yet overdose rates remained high due to increasing potency of adulterants.
  5. Fentanyl pill seizures skyrocketed: Law enforcement seized 2,300 times more fentanyl pills in 2023 (115.5 million) compared to 2017 (49,657), with pills now representing 49% of all fentanyl seizures versus 10% in 2017.

Counterfeit Pills & Youth Impact

  1. Lethality of counterfeit pills increased dramatically: The percentage of fake pills containing lethal fentanyl doses rose from 40% (2020-2021) to 60% (2022) to 70% (2023-2024).
  2. Fentanyl became the leading cause of death in youth aged 15-24: Fentanyl-only deaths now account for the majority of fatal overdoses in this age group, despite overall teen drug use declining.
  3. Social media drug marketplaces exploded: 80% of teen and young adult fentanyl poisoning deaths can be traced to some social media contact, with platforms like Snapchat, Instagram, TikTok, and Telegram becoming “open-air drug markets.”
  4. “One Pill Can Kill” became reality: Just 2 milligrams of fentanyl (the amount on the tip of a pencil) can be lethal, and counterfeit pills are virtually indistinguishable from legitimate prescriptions.
  5. Snapchat became a primary drug distribution platform: Over 1,100 cases in DEA’s “Operation Last Mile” involved social media apps, with disappearing messages feature facilitating untraceable drug transactions.

Regional & Geographic Patterns

  1. Western U.S. fentanyl contamination crisis: By 2025, one in two drug deaths in the Western region were linked to fentanyl contamination of cocaine or methamphetamine, compared to one in three in the Eastern U.S.
  2. Nevada’s methamphetamine predominance: Nevada became an outlier where methamphetamine caused more deaths than fentanyl by 2024-2025.
  3. Regional shifts in fentanyl supply: The Western U.S., which historically had fewer fentanyl seizures, now accounts for the most law enforcement seizures of fentanyl, with 77.8% of Western fentanyl seizures being pills in 2023.

Polysubstance Use Trends

  1. Polysubstance overdose deaths surged: 47% of drug overdose deaths in 2023 involved both opioids and stimulants, marking a “fourth wave” of the opioid epidemic.
  2. Cocaine-fentanyl combinations increased 85%: Cocaine-involved deaths rose 85% from 2019 to 2023, driven primarily by fentanyl contamination.
  3. Stimulant contamination with fentanyl: Users of stimulants like cocaine and methamphetamine increasingly died from accidental fentanyl exposure, with many victims having no opioid tolerance.
  4. Methamphetamine production at record levels: Southeast Asia saw record levels of methamphetamine production, particularly in Myanmar’s Shan State.

COVID-19 Pandemic Impact (2020-2022)

  1. 93,000 overdose deaths in 2020: Drug overdose deaths spiked to an estimated 93,000 in the first year of the pandemic, marking an unprecedented increase.
  2. Social isolation increased solitary drug use: People using drugs alone became more common during lockdowns, dramatically increasing overdose death risk due to lack of immediate help.
  3. 13% of Americans increased substance use during COVID-19: By June 2020, 13% of Americans reported starting or increasing substance use to cope with pandemic-related stress.
  4. 18% immediate increase in overdoses: The early months of the pandemic brought an 18% increase nationwide in overdoses compared to 2019 levels.
  5. Treatment disruptions worsened outcomes: Closures and disruptions to in-person treatment, methadone clinics, harm reduction services, and support groups contributed to rising deaths.
  6. Mental health crisis accelerated substance use: Reports of anxiety or depression jumped from 1 in 10 adults pre-pandemic to 4 in 10 during the pandemic, correlating with increased substance use.

Dramatic Decline Period (2023-2025)

  1. Historic overdose death decline in 2024: Drug overdose deaths decreased 26.9% from 2023 to 2024, reaching approximately 80,391 deaths—the lowest level since 2019 and the largest single-year reduction ever recorded.
  2. 11 consecutive months of decline: From October 2023 through October 2024, the U.S. saw 11 consecutive months of declining overdose deaths.
  3. State-level improvements: Michigan, West Virginia, Louisiana, Ohio, Virginia, Wisconsin, and Washington D.C. experienced overdose death reductions exceeding 35% between 2023 and 2024.

Treatment & Response Trends

  1. Naloxone accessibility expanded: Over-the-counter naloxone availability and community distribution programs significantly increased, contributing to declining death rates.
  2. Buprenorphine prescribing barriers removed: The elimination of the X-Waiver requirement in the MAT Act allowed all healthcare providers with DEA licenses to prescribe buprenorphine, dramatically expanding access.
  3. Treatment gap remained massive: Despite progress, 80% of people who needed substance use treatment in 2024 did not receive it, and only 17% of those with opioid use disorder received MOUD.
  4. Gas station drugs proliferated: Substances like tianeptine (“gas station heroin”), Delta-8 THC, kratom, and synthetic cannabinoids became widely available at convenience stores, creating new addiction pathways particularly dangerous for youth.

References

Centers for Disease Control and Prevention. (2024). Drug overdose deaths in the United States, 2003–2023 (NCHS Data Brief No. 522). National Center for Health Statistics. https://www.cdc.gov/nchs/products/databriefs/db522.htm

Centers for Disease Control and Prevention. (2024, June 27). Treatment for opioid use disorder: Population estimates—United States, 2022. Morbidity and Mortality Weekly Report, 73(25), 567–574. https://www.cdc.gov/mmwr/volumes/73/wr/mm7325a1.htm

Centers for Disease Control and Prevention. (2025). About overdose prevention. https://www.cdc.gov/overdose-prevention/about/index.html

Centers for Disease Control and Prevention. (2025). Understanding the opioid overdose epidemic. https://www.cdc.gov/overdose-prevention/about/understanding-the-opioid-overdose-epidemic.html

Centers for Disease Control and Prevention. (2025, January 16). Data resources. Overdose Prevention. https://www.cdc.gov/overdose-prevention/data-research/facts-stats/index.html

Centers for Disease Control and Prevention. (2025, February 25). CDC reports nearly 24% decline in U.S. drug overdose deaths [Press release]. https://www.cdc.gov/media/releases/2025/2025-cdc-reports-decline-in-us-drug-overdose-deaths.html

Centers for Disease Control and Prevention. (2025, May 14). U.S. overdose deaths decrease almost 27% in 2024 [Press release]. https://www.cdc.gov/nchs/pressroom/releases/20250514.html

Centers for Disease Control and Prevention. (n.d.). Medications for opioid use disorder (MOUD) study. https://www.cdc.gov/overdose-prevention/data-research/facts-stats/moud-study.html

Centers for Disease Control and Prevention. (n.d.). Products – Vital statistics rapid release – Provisional drug overdose data. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm

Centers for Disease Control and Prevention. (n.d.). Treatment of opioid use disorder. https://www.cdc.gov/overdose-prevention/treatment/opioid-use-disorder.html

Council on Foreign Relations. (2025, October 30). Fentanyl and the U.S. opioid epidemic. https://www.cfr.org/backgrounders/fentanyl-and-us-opioid-epidemic

Dever, J. A., Hertz, M. F., Dunlap, L. J., Richardson, J. S., Wolicki, S. B., Biggers, B. B., Edlund, M. J., Bohm, M. K., Turcios, D., Jiang, X., Zhou, H., Evans, M. E., & Guy, G. P., Jr. (2024). The medications for opioid use disorder study: Methods and initial outcomes from an 18-month study of patients in treatment for opioid use disorder. Public Health Reports, 139(4), 484–493. https://doi.org/10.1177/00333549231222479

Garnett, M. F., & Miniño, A. M. (2024). Drug overdose deaths in the United States, 2002–2022 (NCHS Data Brief No. 491). National Center for Health Statistics. https://doi.org/10.15620/cdc/170565

Gold, M. (2025, July 2). Abuse drugs and trends we’re up against in the U.S. Psychology Today. https://www.psychologytoday.com/us/blog/addiction-outlook/202505/abuse-drugs-and-trends-were-up-against-in-the-us

Krawczyk, N., Rivera, B. D., Jent, V., Keyes, K. M., Jones, C. M., & Cerdá, M. (2021). Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019. International Journal of Drug Policy, 110, 103786. https://doi.org/10.1016/j.drugpo.2021.103786

Legislative Analysis and Public Policy Association. (2025, July). Online drug markets and lawsuits against Snapchat. https://legislativeanalysis.org/wp-content/uploads/2025/07/Snapchat-Fact-Sheet-Final.pdf

National Association of Counties. (2025, August 13). SAMHSA releases new 2024 data on rates of mental illness and substance use disorder in the U.S. https://www.naco.org/news/samhsa-releases-new-2024-data-rates-mental-illness-and-substance-use-disorder-us

National Institute on Drug Abuse. (2024, May 13). Over 115 million pills containing illicit fentanyl seized by law enforcement in 2023 [Press release]. https://nida.nih.gov/news-events/news-releases/2024/05/over-115-million-pills-containing-illicit-fentanyl-seized-by-law-enforcement-in-2023

National Institute on Drug Abuse. (2024, August 21). Drug overdose deaths: Facts and figures. https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates

National Institute on Drug Abuse. (2025, January 9). COVID-19 and substance use. https://nida.nih.gov/research-topics/covid-19-substance-use

New York State Department of Health. (2025, December 19). New York State Department of Health warns of highly potent synthetic sedative more powerful than xylazine emerging in drug checking samples [Press release]. https://www.health.ny.gov/press/releases/2025/2025-12-19_synthetic_sedative.htm

Nova Transformations. (2025, December 8). New drug trends in 2025: Nitazenes, fentanyl & emerging threats. https://novatransformations.com/new-drug-trends-in-2025-nitazenes-fentanyl-emerging-threats-charlotte-nc/

NYU Langone Health. (2022, August 4). Almost 90 percent of people with opioid use disorder not receiving lifesaving medication [Press release]. https://nyulangone.org/news/almost-90-percent-people-opioid-use-disorder-not-receiving-lifesaving-medication

Overdose Lifeline. (2025). 2024 opioid overdose data report: Key trends and insights. https://www.overdoselifeline.org/news/2024-opioid-overdose-data-report-key-trends-and-insights/

PBS NewsHour. (2024, September 12). How social media became a storefront for deadly fake pills laced with fentanyl. https://www.pbs.org/newshour/nation/how-social-media-became-a-storefront-for-deadly-fake-pills-laced-with-fentanyl

Substance Abuse and Mental Health Services Administration. (2025). Key substance use and mental health indicators in the United States: Results from the 2024 National Survey on Drug Use and Health (HHS Publication No. PEP25-07-007, NSDUH Series H-60). Center for Behavioral Health Statistics and Quality. https://www.samhsa.gov/data/data-we-collect/nsduh-national-survey-drug-use-and-health/national-releases

Substance Abuse and Mental Health Services Administration. (2025, July 28). SAMHSA releases annual national survey on drug use and health [Press release]. https://www.samhsa.gov/newsroom/press-announcements/20250728/samhsa-releases-annual-national-survey-on-drug-use-and-health

Substance Abuse and Mental Health Services Administration. (n.d.). 2024 National Substance Use and Mental Health Services Survey (N-SUMHSS): Data on substance use and mental health treatment facilities. https://www.samhsa.gov/data/report/2024-n-sumhss-annual-report

Substance Abuse and Mental Health Services Administration. (n.d.). 2026 Substance Use Disorder Treatment Month. https://www.samhsa.gov/about/digital-toolkits/substance-use-disorder-treatment-month

U.S. Drug Enforcement Administration. (2025, May 15). DEA releases 2025 National Drug Threat Assessment [Press release]. https://www.dea.gov/press-releases/2025/05/15/dea-releases-2025-national-drug-threat-assessment

U.S. Food and Drug Administration. (n.d.). Information about medications for opioid use disorder (MOUD). https://www.fda.gov/drugs/information-drug-class/information-about-medications-opioid-use-disorder-moud

USAFacts. (2025, October 24). Are fentanyl overdose deaths rising in the US? https://usafacts.org/articles/are-fentanyl-overdose-deaths-rising-in-the-us/

ABOUT THE AUTHOR

Olivia MacLean
I’m an SEO strategist at Webserv, where I focus on the intersection of strategy, AI, and automation to drive smarter, scalable growth. My work blends creative insight with data-backed decision-making, helping brands connect with audiences in ways that are both human and efficient. I’m passionate about building systems that make marketing work better, not harder. From intelligent content strategies to automated workflows that free up space for big-picture thinking. When I’m not deep in analytics or testing a new AI tool, you’ll probably find me planning my next creative project, exploring Toronto, or diving into something new just for the fun of it.
Table of Contents

Rehab Marketing Services

See the whole Patient Acquisition System

We've spent 9 years marketing treatment centers and have curated the perfect set of services to help rehabs attract their perfect patients from the first click to admission.

Organic Admissions

Build sustainable, long-term patient acquisition through search visibility and content authority.

SEO Content Marketing Digital PR AEO

Paid Admissions

Drive immediate results with targeted advertising and optimized conversion experiences.

Paid Search Paid Social Conversion Rate Optimization

Admission Ops

Streamline your admissions process with data-driven operations and conversion tracking.

Admission Operations Billing

Ready to Grow?

Partner with the leading agency for Rehabs.

Trusted by 200+ Treatment centers nationwide

gallus logo
refine logo
damore logo
new method wellness logo
alina lodge